BrainStorm Cell Therapeutics on the Road to Clinical Studies in Parkinson’s Disease

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies and therapeutics, is pleased to announce preliminary results from its first safety supporting experiment.
Business Wire